Heparan sulfate proteoglycans on the cell surface: Versatile coordinators of cellular functions

International Journal of Biochemistry and Cell Biology

Volumn 32, Issue 3, 2000, Pages 269-288

  Tumova, Sarka ^a   Woods, Anne ^a   Couchman, John R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adhesion; Development; Glypican; Heparan sulfate proteoglycan; Syndecan

Indexed keywords

CELL ADHESION MOLECULE; GLYCOSAMINOGLYCAN; GLYPICAN; GROWTH FACTOR RECEPTOR; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SYNDECAN;

CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; COVALENT BOND; EXTRACELLULAR MATRIX; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARBOHYDRATE SEQUENCE; CELL MEMBRANE; EMBRYONIC AND FETAL DEVELOPMENT; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NEOPLASMS; WOUND HEALING;

EID: 0033959545     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(99)00116-8     Document Type: Article

References (149)

1. Nader H.B., Dietrich C.P. Natural occurrence, and possible biological role of heparin. Heparin. 1989;81-96 CRC Press, Inc, Boca Raton, FL.
2. Bernfield M., Kokenyesi R., Kato M., Hinkes M.T., Spring J., Gallo R.L., Lose E.J. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Ann. Rev. Cell Biol. 8:1992;365-393.
3. Rapraeger A.C. The coordinated regulation of heparan sulfate, syndecans and cell behavior. Curr. Opin. Cell Biol. 5:1993;844-853.
4. Wight T.N., Kinsella M.G., Qwarnström E.E. The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Opin. Cell Biol. 4:1992;793-801.
5. Couchman J.R., Woods A. Syndecans, signaling and cell adhesion. J. Cell. Biochem. 61:1996;578-584.
6. M. Bernfield, M. Gotte, P.W. Park, O. Reizes, M.L. Fitzgerald, J. Lincecum, M. Zako, Functions of cell surface heparan sulfate proteoglycans, Annu. Rev. Biochem. 68 (1999) 729-777.
7. Jackson R.L., Busch S.J., Cardin A.D. Glycosaminoglycans: molecular properties, protein interactions and role in physiological processes. Phys. Rev. 71:1991;481-538.
8. Kjellén L., Lindahl U. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60:1991;443-475.
9. Lindahl U., Kusche-Gullberg M., Kjellén L. Regulated diversity of heparan sulfate. J. Biol. Chem. 273:1998;24979-24982.
10. Stringer S.E., Gallagher J.T. Heparan sulphate. Int. J. Biochem. Cell Biol. 29:1997;709-714.
11. David G. Integral membrane heparan sulfate proteoglycans. FASEB J. 7:1993;1023-1030.
12. Carey D.J. Syndecans: multifunctional cell-surface coreceptors. Biochem. J. 327:1997;1-16.
13. Rapraeger A.C., Ott V.L. Molecular interactions of the syndecan core proteins. Curr. Opin. Cell Biol. 10:1998;620-628.
14. Yanagishita M. Glycosylphosphatidylinositol-anchored and core protein-intercalated heparan sulfate proteoglycans in rat ovarian granulosa cells have distinct secretory, endocytic and intracellular degradative pathways. J. Biol. Chem. 267:1992;9505-9511.
15. Fransson L.-Å., Edgren G., Havsmark B., Schmidtchen A. Recycling of a glycosylphosphatidylinositol-anchored heparan sulphate proteoglycan (glypican) in skin fibroblasts. Glycobiology. 5:1995;407-415.
16. Brown T.A., Bouchard T., St. John T., Wayner E., Carter W.G. Human keratinocytes express a new CD44-core protein (CD44E) as a heparan sulfate intrinsic membrane proteoglycan with additional exons. J. Cell Biol. 113:1991;207-221.
17. López-Casillas F., Cheifetz S., Doody J., Andres J.L., Lane W.S., Massague J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell. 67:1991;785-795.
18. Esko J.D., Zhang L. Influence of core protein sequence on glycosaminoglycan assembly. Curr. Opin. Struct. Biol. 6:1996;663-670.
19. Chen R.L., Lander A.D. Preferential assembly of heparan sulfate on glypican-1 is regulated by core protein structures distant from the site of glycosaminoglycan attachment. Mol. Biol. Cell. 9:1998;56a.
20. Salmivirta M., Lidholt K., Lindahl U. Heparan sulfate: a piece of information. FASEB J. 10:1996;1270-1279.
21. Aikawa J., Esko J.D. Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/N-sulfotransferase family. J. Biol. Chem. 274:1999;2690-2695.
22. Conrad H.E. Antithrombin, the prototypic heparin-binding protein. Heparin-binding Proteins. 1998;203-238 Academic press, San Diego, CA.
23. Liu J., Shworak N.W., Sinaÿ P., Schwartz J.J., Zhang L., Fritze L.M.S., Rosenberg R.D. Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities. J. Biol. Chem. 274:1999;5185-5192.
24. Sasisekharan R., Ernst S., Venkataraman G. On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans. Angiogenesis. 1:1997;45-54.
25. Lortat-Jacob H., Turnbull J.E., Grimaud J.-A. Molecular organization of the interferon gamma-binding domain in heparan sulphate. Biochem. J. 310:1995;497-505.
26. Pillarisetti S., Paka L., Sasaki A., Vanni-Reyes T., Yin B., Parthasarathy N., Wagner W.D., Goldberg I.J. Endothelial cell heparanase modulation of lipoprotein lipase activity. Evidence that heparan sulfate oligosaccharide is an extracellular chaperone. J. Biol. Chem. 272:1997;15753-15759.
27. Vlodavsky I., Miao H.-Q., Medalion B., Danagher P., Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Met. Rev. 15:1996;177-186.
28. Berryman D.E., Bensadoun A. Heparan sulfate proteoglycans are primarily responsible for the maintenance of enzyme activity, binding and degradation of lipoprotein lipase in Chinese hamster ovary cells. J. Biol. Chem. 270:1995;24525-24531.
29. Murphy-Ullrich J.E., Westrick L.G., Esko J.D., Mosher D.F. Altered metabolism of thrombospondin by Chinese hamster ovary cells defective in glycosaminoglycan synthesis. J. Biol. Chem. 263:1988;6400-6406.
30. Gallagher J.T. The interaction and regulation of basic and acidic fibroblast growth factors by heparan sulfate. TIGG. 10:1998;137-144.
31. Faham S. Diversity does make a difference: fibroblast growth factor-heparin interactions. Curr. Opin. Struct. Biol. 8:1998;578-585.
32. Bourin M.-C., Lindahl U. Glycosaminoglycans and the regulation of blood coagulation. Biochem. J. 289:1993;313-330.
33. Thompson L.D., Pantoliano M.W., Springer B.A. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochemistry. 33:1994;3831-3840.
34. Casu B., Petitou M., Provasoli M., Sinaÿ P. Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. TIBS. 13:1988;221-225.
35. Hileman R.E., Fromm J.R., Weiler J.M., Linhardt R.J. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays. 20:1998;156-167.
36. Lander A. Proteoglycans: master regulators of molecular encounter? Matrix Biol. 17:1998;465-472.
37. Nurcombe V., Ford M.D., Wildschut J.A., Bartlett P.F. Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science. 260:1993;103-106.
38. Brickman Y.G., Nurcombe V., Ford M.D., Gallagher J.T., Bartlett P.F., Turnbull J.E. Structural comparison of fibroblast growth factor-specific heparan sulfates derived from a growing or differentiating neuroepithelial cell line. Glycobiology. 8:1998;463-471.
39. Kato M., Wang H., Bernfield M., Gallagher J.T., Turnbull J.E. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand-binding of its heparan sulfate chains. J. Biol. Chem. 269:1994;1-18890.
40. Jayson G.C., Lyon M., Paraskeva C., Turnbull J.E., Deakin J.A., Gallagher J.T. Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J. Biol. Chem. 273:1998;51-57.
41. Safaiyan F., Lindahl U., Salmivirta M. Selective reduction of 6-sulfation in heparan sulfate from transformed mammary epithelial cells. Eur. J. Biochem. 252:1998;576-582.
42. Winterbourne D.J., Mora P.T. Cells selected for high tumorigenicity or transformed by Simian Virus 40 synthesize heparan sulfate with reduced degree of sulfation. J. Biol. Chem. 256:1981;4310-4320.
43. Steinfeld R., Van Den Berghe H., David G. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J. Cell Biol. 133:1996;405-416.
44. Tumova S., Hatch B.A., Law D.J., Bame K.J. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products. Biochem. J. 337:1999;471-479.
45. Kato M., Wang H., Kainulainen V., Fitzgerald M.L., Ledbetter S., Ornitz D.M., Bernfield M. Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nature Med. 4:1998;691-697.
46. Brown K.J., Parish C.R. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor. Biochemistry. 33:1994;13918-13927.
47. Woods A., Oh E.-S., Couchman J.R. Syndecan proteoglycans and cell adhesion. Matrix Biol. 17:1998;477-483.
48. Woods A., Couchman J.R. Syndecans: synergistic activators of cell adhesion. Trends Cell Biol. 8:1998;189-192.
49. M. Bernfield, M.T. Hinkes, R.L. Gallo, Developmental expression of the syndecans: possible function and regulation, Development Supplement (1993) 205-212.
50. Kim C.W., Goldberger O.A., Gallo R.L., Bernfield M. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue- and development-specific patterns. Mol. Biol. Cell. 5:1994;797-805.
51. Litwack E.D., Ivins J.K., Kumbasar A., Paine-Saunders S., Stipp C.S., Lander A.D. Expression of heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev. Dyn. 211:1998;72-87.
52. Herndon M.E., Stipp C.S., Lander A.D. Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding. Glycobiology. 9:1999;143-155.
53. Gao Y., Simons M. Identification of syndecan-4 cytoplasmic domain-binding proteins. Mol. Biol. Cell. 9:1998;56a.
54. Cohen A.R., Wood D.F., Marfatia S.M., Walther Z., Chishti A.H., Anderson J.M. Human CASK/LIN-2 binds syndecan-2 and Protein 4.1 and localizes to the basolateral membrane of epithelial cells. J. Cell Biol. 142:1998;129-138.
55. Hsueh Y.-P., Yang F.-C., Kharazia V., Naisbitt S., Cohen A.R., Weinberg R.J., Sheng M. Direct interaction of CASK/LIN-2 and syndecan heparan sulfate proteoglycan and their overlapping distribution in neuronal synapses. J. Cell Biol. 142:1998;139-151.
56. Ethell I.M., Yamaguchi Y. Cell surface heparan sulfate proteoglycan syndecan-2 induces the maturation of dendritic spines in rat hippocampal neurons. J. Cell Biol. 144:1999;575-586.
57. Kinnunen T., Kaksonen M., Saarinen J., Kalkkinen N., Peng H.B., Rauvala H. Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J. Biol. Chem. 273:1998;10702-10708.
58. Woods A., McCarthy J.B., Furcht L.T., Couchman J.R. A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol. Biol. Cell. 4:1993;605-613.
59. Lee D., Oh E.-S., Woods A., Couchman J.R., Lee W. Solution structure of a syndecan-4 cytoplasmic domain and its interaction with phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem. 273:1998;13022-13029.
60. Woods A., Couchman J.R., Johansson S., Hook M. Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. EMBO J. 5:1986;665-670.
61. Horowitz A., Simons M. Regulation of syndecan-4 phosphorylation in vivo. J. Biol. Chem. 273:1998;10914-10918.
62. Horowitz A., Simons M. Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase C alpha. J. Biol. Chem. 273:1998;25548-25551.
63. Lyon M., Gallagher J.T. Hepatocyte growth factor/scatter factor: a heparan sulfate-binding pleiotropic growth factor. Biochem. Soc. Trans. 22:1994;365-370.
64. Feyzi E., Lustig F., Fager G., Spillmann D., Lindahl U., Salmivirta M. Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain. J. Biol. Chem. 272:1997;5518-5524.
65. Higashiyama S., Abraham J.A., Klgsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J. Cell Biol. 122:1993;933-940.
66. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:1999;9-22.
67. McFadden G., Kelvin D. New strategies for chemokine inhibition and modulation. You take the high road and I'll take the low road. Biochem. Pharm. 54:1997;1271-1280.
68. Ornitz D.M., Yayon A., Flanagan J.G., Svahn C.M., Levi E., Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12:1992;240-247.
69. Turnbull J.E., Fernig D.G., Ke Y., Wilkinson M.C., Gallagher J.T. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J. Biol. Chem. 267:1992;10337-10341.
70. Basilico C., Moscatelli D. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59:1992;115-165.
71. Olwin B.B., Arthur K., Hannon K., Hein P., McFall A., Riley B., Szebenyi G., Zhou Z., Zuber M.E., Rapraeger A.C., Fallon J.F., Kudla A.J. Role of FGFs in skeletal muscle and limb development. Mol. Reprod. Dev. 39:1994;90-101.
72. Givol D., Yayon A. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 6:1992;3362-3369.
73. Faham S., Hileman R.E., Fromm J.R., Linhardt R.J., Rees D.C. Heparin structure and interactions with basic fibroblast growth factor. Science. 271:1996;1116-1120.
74. Ornitz D.M., Herr A.B., Nilsson M., Westman J., Svahn C.-M., Waksman G. FGF binding and FGF receptor activation by synthetic heparan derived di- and trisaccharides. Science. 268:1995;432-436.
75. Waksman G., Herr A.B. New insights into heparin-induced FGF oligomerization. Nature Struct. Biol. 5:1998;527-530.
76. Spivak-Kroizman T., Lemmon M.A., Dikic I., Ladbury J.E., Pinchasi D., Huang J., Jaye M., Crumley G., Schlessinger J., Lax I. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation and cell proliferation. Cell. 79:1994;1015-1024.
77. DiGabriele A.D., Lax I., Chen D.I., Svahn C.M., Jaye M., Schlessinger J., Hendrickson W.A. Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature. 393:1998;812-817.
78. Venkataraman G., Shriver Z., Davis J.C., Sasisekharan R. Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans. Proc. Natl. Acad. Sci. USA. 96:1999;1892-1897.
79. Chirgadze D.Y., Hepple J.P., Zhou H., Byrd R.A., Blundell T.L., Gherardi E. Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding. Nature Struct. Biol. 6:1999;72-78.
80. Roghani M., Moscatelli D. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J. Biol. Chem. 267:1992;22156-22162.
81. Sperinde G.V., Nugent M.A. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells. Biochemistry. 37:1998;13153-13164.
82. Baldin V., Roman A.-M., Bosc-Bierne I., Amalric F., Bouche G. Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J. 9:1990;1511-1517.
83. Rifkin D.B., Moscatelli D., Roghani M., Nagano Y., Quarto N., Klein S., Bikfalvi A. Studies on FGF-2: nuclear localization and function of high molecular weight forms and receptor binding in the absence of heparin. Mol. Reprod. Dev. 39:1994;102-105.
84. Maher P.A. Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J. Cell Biol. 134:1996;529-536.
85. Kojima T., Leone C.W., Marchildon G.A., Marcum J.A., Rosenberg R.D. Isolation and characterization of heparn sulfate proteoglycans produced by cloned rat microvascular endothelial cells. J. Biol. Chem. 267:1992;4859-4869.
86. Rosenberg R.D., Shworak N.W., Liu J., Schwartz J.J., Zhang L. Heparan sulfate proteoglycans of the cardiovascular system: specific structures emerge but how is synthesis regulated? J. Clin. Invest. 99:1997;2062-2070.
87. Fuki I.V., Kuhn K.M., Lomazov I.R., Rothman V.L., Tuszynski G.P., Iozzo R.V., Swenson T.L., Fisher E.A., Williams K.J. The syndecan family of proteoglycans: novel receptors mediating internalization of atherogenic lipoproteins in vitro. J. Clin. Invest. 100:1997;1611-1622.
88. Sutherland A.E., Sanderson A.D., Mayes M., Seibert M., Calarco P.G., Bernfield M., Damsky C.H. Expression of syndecan, a putative low affinity fibroblast growth factor receptor, in the early mouse embryo. Development. 113:1991;339-351.
89. Gallo R.L., Siebert E., Bernfield M. Members of the syndecan family of heparan sulfate proteoglycans show distinct expression during mouse development. Mol. Biol. Cell. 4:1993;413a.
90. Teel A.L., Yost H.J. Embryonic expression patterns of Xenopus syndecans. Mech. Dev. 59:1996;115-127.
91. David G., Bai X.M., Van der Schueren B., Marynen P., Cassiman J.-J., Van den Berghe H. Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development. 119:1993;841-854.
92. Gould S.E., Upholt W.B., Kosher R.A. Characterization of chicken syndecan-3 as a heparan sulfate proteoglycan and its expression during embryogenesis. Dev. Biol. 168:1995;438-451.
93. Carey D.J., Evans D.M., Stahl R.C., Asundi V.K., Conner K.J., Garbes P., Cizmeci-Smith G. Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan. J. Cell Biol. 117:1992;191-201.
94. Asundi V., Keister B.F., Stahl R.C., Carey D.J. Developmental and cell-type-specific expression of cell surface heparan sulfate proteoglycans in the rat heart. Exp. Cell Res. 230:1997;145-153.
95. Ivins J.K., Litwack E.D., Kumbasar A., Stipp C.S., Lander A.D. Cerebroglycan, a developmentally regulated cell-surface heparan sulfate proteoglycan, is expressed on developing axons and growth cones. Dev. Biol. 184:1997;320-332.
96. Saunders S., Paine-Saunders S., Lander A.D. Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb and brain. Dev. Biol. 190:1997;78-93.
97. Pilia G., Hughes-Benzie R.M., MacKenzie A., Baybayan P., Chen E.Y., Huber R., Neri G., Cao A., Forabosco A., Schlessinger D. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat. Genet. 12:1996;241-247.
98. Gonzalez A.D., Kaya M., Shi W., Song H., Testa J.R., Penn L.Z., Filmus J. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. J. Cell Biol. 141:1998;1407-1414.
99. David G., Bai X.M., Van Der Schueren B., Cassiman J.-J., Van Den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J. Cell Biol. 119:1992;961-975.
100. S.M.B. Jeronimo, C.P. Dietrich, H.B. Nader, Structure of sulfated glycosaminoglycans synthesized during the ontogeny of the mollusc Pomacea Sp, 93B (1989) 899-903.
101. Cumberledge S., Reichsman F. Glycosaminoglycans and WNTs: just a spoonful of sugar helps the signal go down. TIG. 13:1997;421-423.
102. Haerry T.E., Heslip T.R., Marsh J.L., O'Connor M.B. Defects in glucuronate biosynthesis disrupt Wingless signaling in Drosophila. Development. 124:1997;3055-3064.
103. Itoh K., Sokol S.Y. Heparan sulfate proteoglycans are required for mesoderm induction in Xenopus embryos. Development. 120:1994;2703-2711.
104. Brickman M.C., Gerhart J.C. Heparitinase inhibition of mesoderm induction and gastrulation in Xenopus laevis embryos. Dev. Biol. 164:1994;484-501.
105. Yost H.J. Regulation of vertebrate left-right asymmetries by extracellular matrix. Nature. 357:1992;158-161.
106. Yost H.J. Inhibition of proteoglycan synthesis eliminates left-right asymmetry in Xenopus laevis cardiac looping. Development. 110:1990;865-874.
107. Walz A., McFarlane S., Brickman Y.G., Nurcombe V., Bartlett P.F., Holt C.E. Essential role of heparan sulfates in axon navigation and targeting in the developing visual system. Development. 124:1997;2421-2430.
108. Sen J., Goltz J.S., Stevens L., Stein D. Spatially restricted expression of pipe in the Drosophila egg chamber defines embryonic dorsal-ventral polarity. Cell. 95:1998;471-481.
109. Feyzi E., Saldeen T., Larsson E., Lindahl U., Salmivirta M. Age-dependent modulation of heparan sulfate structure and function. J. Biol. Chem. 273:1998;13395-13398.
110. Murata K., Murata A., Yoshida K. Heparan sulfate isomers in cerebral arteries of Japanese women with aging and with atherosclerosis-heparitinase and high-performance liquid chromatography determinations. Atherosclerosis. 132:1997;9-17.
111. Elenius K., Vainio S., Laato M., Salmivirta M., Thesleff I., Jalkanen M. Induced expression of syndecan in healing wounds. J. Cell Biol. 114:1991;585-595.
112. Kainulainen V., Wang H., Schick C., Bernfield M. Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids. J. Biol. Chem. 273:1998;11563-11569.
113. Gallo R.L., Ono M., Povsic T., Page C., Eriksson E., Klagsbrun M., Bernfield M. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. USA. 91:1994;11035-11039.
114. Cizmeci-Smith G., Langan E., Youkey J., Showalter L.J., Carey D.J. Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells. Atheroscler. Thromb. Vasc. Biol. 17:1997;172-180.
115. Jaakkola P., Kontusaari S., Kauppi T., Määttä A., Jalkanen M. Wound reepithialization activates a growth factor-responsive enhancer in migrating keratinocytes. FASEB J. 12:1998;959-969.
116. Gallo R., Kim C., Kokenyesi R., Adzik N.S., Bernfield M. Syndecan-1 and -4 are induced during wound repair of neonatal but not fetal skin. J. Invest. Dermatol. 107:1996;676-683.
117. Trautman M.S., Kimelman J., Bernfield M. Developmental expression of syndecan, an integral membrane proteoglycan, correlates with cell differentiation. Development. 111:1991;213-220.
118. Inki P., Jalkanen M. The role of syndecan-1 in malignancies. Ann. Med. 28:1996;63-67.
119. Kato M., Saunders S., Nguyen H., Bernfield M. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol. Biol. Cell. 6:1995;559-576.
120. Liu W., Litwack E.D., Stanley M.J., Langford J.K., Lander A.D., Sanderson R.D. Heparan sulfate proteoglycans as adhesive and antiinvasive molecules: syndecans and glypican have distinct functions. J. Biol. Chem. 273:1998;22825-22832.
121. Langford J.K., Stanley M.J., Cao D., Sanderson R.D. Multiple heparan sulfate chains are required for optimal syndecan-1 function. J. Biol. Chem. 273:1998;29965-29971.
122. Sanderson R.D., Lalor P., Bernfield M. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul. 1:1989;27-35.
123. Dhodapkar M.V., Abe E., Theus A., Lacy M., Langford J.K., Barlogie B., Sanderson R.D. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth and bone cell differentiation. Blood. 91:1998;2679-2688.
124. Roskams T., De Vos R., David G., Van Damme B., Desmet V. Heparan sulphate proteoglycan expression in human primary liver tumors. J. Pathol. 185:1998;290-297.
125. Nackaerts N., Verbeken E., Deneffe G., Vanderschueren B., Demedts M., David G. Heparan sulfate proteoglycan expression in human lung-cancer cells. Int. J. Cancer. 74:1997;335-345.
126. Kleeff J., Ishiwata T., Kumbasar A., Friess H., Büchler M.W., Lander A.D. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J. Clin. Invest. 102:1998;1662-1673.
127. Lind T., Tufaro F., McCormick C., Lindahl U., Lidholt K. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J. Biol. Chem. 273:1998;26265-26268.
128. Rostand K.S., Esko J.D. Microbial adherence to and invasion through proteoglycans. Infect. Immun. 65:1997;1-8.
129. D. Sawitzky, Protein-glycosaminoglycan interactions: infectiological aspects, Med. Microbiol. Immunol.184 (1996) 155-161.
130. Chen Y., Maguire T., Hileman R.E., Fromm J.R., Esko J.D., Linhardt R.J., Marks R.M. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nature Med. 3:1997;866-871.
131. Haywood A.M. Virus receptors: binding, adhesion strengthening and changes in viral structure. J. Virol. 68:1994;1-5.
132. Shakibaei M., Frevert U. Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans. J. Exp. Med. 184:1996;1699-1711.
133. Dehio C., Freissler E., Lanz C., Gomez-Duarte O.G., David G., Meyer T.F. Ligation of cell surface heparan sulfate proteoglycans by antibody-coated beads stimulates phagocytic uptake into epithelial cells: a model for cellular invasion by Neisseria gonorrhoeae. Exp. Cell Res. 242:1998;528-539.
134. Summerford C., Samulski R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1998;1438-1445.
135. Guimond S., Maccarana M., Olwin B.B., Lindahl U., Rapraeger A.C. Activating and inhibitory sequences for FGF-2 (basic FGF): distinct requirements for FGF-1, FGF-2 and FGF-4. J. Biol. Chem. 268:1993;23906-23914.
136. Ashikari S., Habuchi H., Kimata K. Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor. J. Biol. Chem. 270:1995;29586-29593.
137. Spillmann D., Witt D., Lindahl U. Defining the interleukin-8-binding domain of heparan sulfate. J. Biol. Chem. 273:1998;15487-15493.
138. Stringer S.E., Gallagher J.T. Specific binding of the chemokine platelet factor 4 to heparan sulfate. J. Biol. Chem. 272:1997;20508-20514.
139. Feyzi E., Trybala E., Bergström T., Lindahl U., Spillmann D. Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. J. Biol. Chem. 272:1997;24850-24857.
140. Parthasarathy N., Goldberg I.J., Sivaram P., Mulloy B., Flory D.M., Wagner W.D. Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. J. Biol. Chem. 269:1994;22391-22396.
141. Lindahl U., Thunberg L., Backstrom G., Reisenfeld J., Nordling K., Bjork I. Extension and structural variability of the antithrombin-binding sequence in heparin. J. Biol. Chem. 259:1984;12368-12376.
142. Parthasarathy N., Gotow L.F., Bottoms J.D., Kute T.E., Wagner W.D., Mulloy B. Oligosaccharide sequence of human breast cancer heparan sulfate with high affinity for laminin. J. Biol. Chem. 273:1998;21111-21114.
143. Walker A., Gallagher J.T. Structural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII). Biochem. J. 317:1996;871-877.
144. Pyke C., Kristensen P., Ostergaard P.B., Oturai P.S., Romer J. Proteoglycan expression in the normal rat kidney. Nephron. 77:1997;461-470.
145. Carey D.J., Evans D.M., Stahl R.C., Asundi V.K., Conner K.J., Garbes P., Cizmeci-Smith G. Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan. J. Cell Biol. 117:1992;191-201.
146. Gould S.E., Upholt W.B., Kosher R.A. Syndecan 3: a member of the syndecan family of membrane-intercalated proteoglycans that is expressed in high amounts at the onset of chicken limb cartilage differentiation. Proc. Natl. Acad. Sci. USA. 89:1992;3271-3275.
147. Watanabe K.Y.H., Yamaguchi Y. K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. J. Cell Biol. 130:1995;1207-1218.
148. Stipp C.S., Litwack E.D., Lander A.D. Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation. J. Cell Biol. 124:1994;149-160.
149. Veugelers M., Vermeesch J., Reekmans G., Steinfeld R., Marynen P., David G. Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family. Genomics. 40:1997;24-30.